(Q43502400)

24 November 2017

title

Chronic hepatitis B infection in adolescents who received primary infantile vaccination (English)

1 reference

24 November 2017

1 reference

1 reference

1 reference

Tzu-Wei Wu

1

1 reference

24 November 2017

Hans Hsienhong Lin

series ordinal

2

1 reference

24 November 2017

Li-Yu Wang

series ordinal

3

1 reference

24 November 2017

language of work or name

English

0 references

publication date

28 December 2012

1 reference

24 November 2017

1 reference

24 November 2017

volume

57

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

37-45

1 reference

Vertical Transmission of Hepatitis B Antigen in Taiwan

24 November 2017

cites work

1 reference

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

21 January 2018

1 reference

Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers

21 January 2018

1 reference

A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers

21 January 2018

1 reference

Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia

21 January 2018

1 reference

Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan

21 January 2018

1 reference

Trend of hepatitis B virus infection in freshmen classes at two high schools in Hualien, Taiwan from 1991 to 1999.

21 January 2018

1 reference

Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area

21 January 2018

1 reference

Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination

21 January 2018

1 reference

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers

21 January 2018

1 reference

Passive-active immunization in infants of hepatitis Be antigen-positive mothers. Comparison of the efficacy of early and delayed active immunization

21 January 2018

1 reference

Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980-1994.

21 January 2018

1 reference

Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.

21 January 2018

1 reference

Mother-to-infant transmission of hepatitis B virus: a Chinese experience

21 January 2018

1 reference

Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.

21 January 2018

1 reference

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.

21 January 2018

1 reference

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

21 January 2018

1 reference

Adolescent and young adult HPV vaccination in Australia: achievements and challenges.

21 January 2018

1 reference

21 January 2018

1 reference

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.

21 January 2018

1 reference

Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine

21 January 2018

1 reference

Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine

21 January 2018

1 reference

Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins

21 January 2018

1 reference

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

Hepatitis B virus DNA levels and outcomes in chronic hepatitis B.

21 January 2018

1 reference

Prevention of mother-to-child transmission of HIV: antiretroviral strategies

21 January 2018

1 reference

Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings

21 January 2018

1 reference

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection

21 January 2018

1 reference

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection

21 January 2018

1 reference

Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization

21 January 2018

1 reference

Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen

21 January 2018

1 reference

Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination

21 January 2018

1 reference

Efficacy of a mass hepatitis B immunization program after switching to recombinant hepatitis B vaccine: a population-based study in Taiwan

21 January 2018

1 reference

Hepatitis B surface antigenemia at birth: A long-term follow-up study

21 January 2018

1 reference

Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study

21 January 2018

1 reference

7 January 2021

Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field

1 reference

7 January 2021

Hepatitis B vaccination in high-risk infants: 10-year follow-up

1 reference

7 January 2021

Ethnicity, substance use, and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination

1 reference

7 January 2021

Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago

1 reference

7 January 2021

What level of hepatitis B antibody is protective?

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.25988

1 reference

24 November 2017

1 reference